Sona Nanotech Income Statement

Financials in millions CAD. Fiscal year is November - October.

Millions CAD. Fiscal year is Nov - Oct.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan '26 Jan 31, 2026	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021
Selling, General & Admin	1.35	1.39	1.56	1.63	1.74	2.41
Research & Development	0.55	0.73	0.19	0.23	-0.25	-0.04
Amortization of Goodwill & Intangibles	0.72	0.72	0.72	0.42	-	-
Operating Expenses	3.1	3.33	2.84	2.61	3.02	10.67
Operating Income	-3.1	-3.33	-2.84	-2.61	-3.02	-10.67
Interest Expense	-0.04	-0.04	-0.05	-0.07	-0.08	-0.02
Currency Exchange Gain (Loss)	0.01	-0.01	0	-0.01	-0.01	0.04
Other Non Operating Income (Expenses)	-	-	-	-	0.17	-
EBT Excluding Unusual Items	-3.12	-3.38	-2.88	-2.69	-2.94	-10.65
Gain (Loss) on Sale of Investments	0	-	-0	-0	-0	0.01
Gain (Loss) on Sale of Assets	-	-	-	0.04	-	-
Other Unusual Items	0.13	0.13	0.18	0.15	0.58	0.28
Pretax Income	-2.99	-3.25	-2.7	-2.5	-2.36	-10.37
Net Income	-2.99	-3.25	-2.7	-2.5	-2.36	-10.37
Net Income to Common	-2.99	-3.25	-2.7	-2.5	-2.36	-10.37
Shares Outstanding (Basic)	113	112	101	86	68	64
Shares Outstanding (Diluted)	113	112	101	86	68	64
Shares Change (YoY)	8.69%	11.79%	17.22%	25.35%	6.80%	6.43%
EPS (Basic)	-0.03	-0.03	-0.03	-0.03	-0.03	-0.16
EPS (Diluted)	-0.03	-0.03	-0.03	-0.03	-0.03	-0.16
Free Cash Flow	-2.08	-1.96	-1.96	-1.26	-1.81	-3.81
Free Cash Flow Per Share	-0.02	-0.02	-0.02	-0.01	-0.03	-0.06
EBITDA	-2.38	-2.61	-2.11	-2.15	-2.96	-10.6
D&A For EBITDA	0.72	0.72	0.73	0.46	0.06	0.07
EBIT	-3.1	-3.33	-2.84	-2.61	-3.02	-10.67

Source: S&P Global Market Intelligence. Standard template. Financial Sources.